(Q34074721)

30 July 2017

1 reference

title

Stroke: antithrombin versus antiplatelet therapy (English)

1 reference

30 July 2017

Bednar MM

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Expert Opinion on Investigational Drugs

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

355-369

1 reference

Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Effect of thrombin inhibition in vascular dementia and silent cerebrovascular disease. An MR spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Laboratory investigation of platelet function: a review of methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Desmin (a low molecular weight dermatan sulphate) versus heparin in the treatment of patients with deep venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

The therapeutic potential of novel anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Acetylsalicylic acid increases tolerance against hypoxic and chemical hypoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Aspirin use and incident stroke in the cardiovascular health study. CHS Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Final report on the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Prospective study of aspirin use and risk of stroke in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Increased thromboxane biosynthesis is associated with poststroke dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

The effect of oral antiplatelet agents on tissue plasminogen activator-mediated thrombolysis in a rabbit model of thromboembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Interactions between endothelial secretogogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Therapeutic benefit. Aspirin revisited in light of the introduction of clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Inhibition of factor VIIa-tissue factor coagulation activity by a hybrid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Inhaled nitric oxide increases coronary artery patency after thrombolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Activation of complement by tissue plasminogen activator, but not acute cerebral ischemia, in a rabbit model of thromboembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Neurite outgrowth activity of protease nexin-1 on neuroblastoma cells requires thrombin inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Interactions between nitric oxide and prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.9.2.355

21 January 2018

Identifiers

DOI

10.1517/13543784.9.2.355

1 reference

30 July 2017

1 reference